PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2172234
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2172234
Metacarpal Joint Implants market size was valued at US$ 1,360.4 Million in 2025, expanding at a CAGR of 6.3% from 2026 to 2033.
Metacarpal joint implants are orthopedic prosthetic devices intended for reconstruction of damaged joints in the hand, at the base of the thumb or fingers. Manufacturers of metacarpal joint implants work on the creation of orthopedic implants that help to substitute the ends of the metacarpal bones located at the bottom of the thumb or finger. The materials for the manufacture of these implants include titanium, silicone, pyrocarbon, and other substances.
These metacarpal joint implants help to restore the joint function and to eliminate pain and other symptoms. In addition, metacarpal joint implants serve for the treatment of osteoarthritis, rheumatoid arthritis, and finger joint injuries that cannot be treated by conventional methods. Metacarpal joint implants are installed into the place where the removed joint used to be, which means that the joint anatomical structure is being restored. Thus, metacarpal joint implants help to restore the functioning of the hand and relieve the pain of the affected joint.
Metacarpal Joint Implants Market- Market Dynamics
Rising Incidence Of Joint Disorders To Boost Market Demand
The rising incidence of joint disorders is driving the demand for metacarpal joint implants. The implants help in recovering the function of joints, reduce pain, and make the patient mobile again. This particular type of implant device is primarily used for joint reconstruction and hand surgeries as a remedy to treat commonly occurring diseases such as osteoarthritis and rheumatoid arthritis. In April 2025, according to the UK government's Musculoskeletal Health Profile, 17.9% of people aged 16 years and above in England suffered from a long-term MSK disorder. This was more pronounced among women, where 20.0% of them were suffering from MSK diseases compared to 15.6% of men. Also, 13.4% of people had two or more long-term conditions, with at least one being an MSK disorder. These findings highlight the substantial burden of joint and musculoskeletal disorders and the need for improved prevention, diagnosis, and treatment services.
The Global Metacarpal Joint Implants market is segmented on the basis of Location, Ligament Type, End User, Biomaterial, and Region.
Based on ligament type, collateral ligament implants hold a substantial share because with the help of such implants, the stability of joints can be restored along with the normal functioning of the metacarpophalangeal joint after the injury or damage. In September 2025, Smith+Nephew obtained extended marketing approval in the United States for REGENETEN(TM) Bioinductive Implant for extra-articular ligament injuries, which included soft tissue ligament injuries. The scope of indications has been extended to include soft tissue repair and the natural body healing process. Therefore, due to joint stabilization and soft tissue repair, this market is poised to witness considerable growth in the forecast period.
Metacarpal Joint Implants Market- Geographical Insights
North America is characterized by well-developed orthopedic healthcare infrastructure and an increased focus on restoring hand function. In October 2026, according to The Joint Commission's orthopedic certification webpage Org, the United States performs more than 1.2 million spinal surgeries performed each year, underscoring the importance of advanced orthopedic healthcare infrastructure. The Joint Commission provides six core orthopedic certifications: hip fracture, hip, knee, and shoulder joint replacement, spinal fusion, and spine surgery. In addition, two advanced certification options are available for spine surgery and total hip and total knee replacement. The Advanced Spine Surgery certificate requires a program to have treated a minimum of 200 patients. Thus encouraging standardized, evidence-based care and improved patient safety.
Germany Metacarpal Joint Implants Market - Country Insights
Germany's Metacarpal Joint Implants market is supported by and fueled by the presence of top-notch healthcare, highly advanced surgical methods, and increased awareness regarding the hazards of musculoskeletal disorders in the aging population. In January 2026, as reported by the International Journal of Environmental Research and Public Health, 287 perfusionists working at 45 cardiac centers in Germany were surveyed on the prevalence of musculoskeletal disorders. Based on the findings from this research, 86% of the participants admitted to having musculoskeletal disorders, creating a great occupational health hazard. In addition, 65.5% of the participants had lower back problems, and 58.9% had neck disorders. Therefore, there is a dire need for increasing awareness of musculoskeletal disorders.
In the Metacarpal Joint Implants market, there are companies such as Additive Orthopaedics, LimaCorporate, Corin Group, ChM, and BioPro Implants. These firms have plans to come up with innovations in joint replacement systems and implants, which will enable the improvement of joint functionality and the recovery of movement capabilities. In January 2025, Corin received FDA 510(k) clearance for its Apollo Hip X system that enables the integration of 3D preoperative planning and intraoperative fluoroscopy for ensuring the accuracy of the total hip arthroplasty. Therefore, the industry-leading companies contribute towards developing innovative metacarpal joint implants because of advancements achieved by the companies.
In February 2026, BioPro's product line containing the Digitalis Silicone Spacer will be used on the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints. There were said to be five sizes of MCP joints and four sizes of PIP joints.